Literature DB >> 7225259

Nifedipine and left ventricular function in beta-blocked patients.

P I Joshi, J J Dalal, M S Ruttley, D J Sheridan, A H Henderson.   

Abstract

We studied the acute effects of nifedipine on left ventricular function and haemodynamics at constant heart rate in patients on beta-blocker therapy. Nifedipine significantly depressed left ventricular peak dP/dt and peak dP/dt x P-1. Nifedipine also significantly reduced systemic vascular resistance: this was associated with decreased systolic blood pressure and increased left ventricular stroke output, with slight non-significant increases of ejection fraction and mean circumferential shortening velocity. There was no change in left ventricular end-diastolic pressure. This clinical study shows that nifedipine increases cardiac output in association with arterial dilatation despite evidence for a negative inotropic effect. Such intrinsic negative inotropic effects would normally be masked by compensatory sympathetic activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7225259      PMCID: PMC482548          DOI: 10.1136/hrt.45.4.457

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  6 in total

1.  CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE.

Authors:  C A CHIDSEY; E BRAUNWALD; A G MORROW
Journal:  Am J Med       Date:  1965-09       Impact factor: 4.965

2.  Left ventricular performance in the conscious dog with chronically denervated heart.

Authors:  M I Noble; J Stubbs; D Trenchard; W Else; J H Eisele; A Guz
Journal:  Cardiovasc Res       Date:  1972-09       Impact factor: 10.787

3.  Mean velocity of fiber shortening. A simplified measure of left ventricular myocardial contractility.

Authors:  J S Karliner; J H Gault; D Eckberg; C B Mullins; J Ross
Journal:  Circulation       Date:  1971-09       Impact factor: 29.690

4.  Assessment of myocardial contractility from ventricular pressure recordings.

Authors:  N S Nejad; M D Klein; I Mirsky; B Lown
Journal:  Cardiovasc Res       Date:  1971-01       Impact factor: 10.787

5.  Measurement of left ventricular volumes in man by single-plane cineangiocardiography.

Authors:  I S Kasser; J W Kennedy
Journal:  Invest Radiol       Date:  1969 Mar-Apr       Impact factor: 6.016

6.  Norepinephrine stores and contractile force of papillary muscle from the failing human heart.

Authors:  C A Chidsey; E H Sonnenblick; A G Morrow; E Braunwald
Journal:  Circulation       Date:  1966-01       Impact factor: 29.690

  6 in total
  38 in total

1.  Kinetics and hemodynamic effects of intravenous nicardipine modified by previous propranolol oral treatment.

Authors:  P Rocha; M Guerret; D David; X Marchand; J C Kahn
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

2.  Investigation of the effects of physiological and vasodilation-induced autonomic activation on the QTc Interval in healthy male subjects.

Authors:  E Berger; K Patel; S Anwar; W Davies; D J Sheridan
Journal:  Br J Clin Pharmacol       Date:  2005-07       Impact factor: 4.335

3.  The effects of intravenous nifedipine on cardiac hemodynamics and contractility in patients with coronary artery disease in the presence or absence of beta adrenergic blockade.

Authors:  O Visioli; R Bolognesi; F Cucchini; R Ferrari
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

Review 4.  Calcium antagonists in patients with heart failure. A review.

Authors:  H Reicher-Reiss; E Barasch
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 5.  Beta-adrenoceptor antagonists plus nifedipine in the treatment of chronic stable angina pectoris.

Authors:  V F Challenor; D G Waller; C F George
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

6.  Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function.

Authors:  I N Findlay; K MacLeod; M Ford; G Gillen; A T Elliott; H J Dargie
Journal:  Br Heart J       Date:  1986-03

Review 7.  Calcium channel antagonists, Part I: Fundamental properties: mechanisms, classification, sites of action.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

8.  The impact of therapeutic reference pricing on innovation in cardiovascular medicine.

Authors:  Desmond Sheridan; Jim Attridge
Journal:  Pharmacoeconomics       Date:  2006-12       Impact factor: 4.981

9.  Diltiazem treatment for the management of ischaemia in patients with poor left ventricular function: safety of long term administration.

Authors:  M J Zema; S Perlmutter; S Mankes; C Nikitopoulos
Journal:  Br Heart J       Date:  1987-11

Review 10.  Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.

Authors:  H Echizen; M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.